CEUS adds to locoregional therapy for liver disease

Contrast-enhanced ultrasound (CEUS) can improve locoregional therapy for treating metastatic disease of the liver, according to early study results presented April 10 at UltraCon. In her presentation, PhD candidate Corinne Wessner from Thomas Jefferson University in Philadelphia, PA, highlighted initial findings from her team’s ongoing work suggesting that microbubble destruction from CEUS triggering is safe and well-tolerated among patients with intrahepatic cholangiocarcinoma (ICC) and metastatic liver disease who also receive transarterial radioembolization with yttrium-90 (Y90-TARE). “When we add the ultrasound-triggered microbubble destruction, we’re increasing the tumor cell death, hopefully sensitizing these tumors,” Wessner said. Corinne Wessner from Thomas Jefferson University discusses early study results at UltraCon showing the potential of ultrasound-triggered microbubble destruction in treating liver disease.Amerigo AllegrettoICC is a rare and aggressive epithelial cell malignancy that arises from the biliary tree in the liver. It consists of about 10% of primary liver cancers. Furthermore, metastatic disease to the liver is common in this area due to hepatic dual blood supply. The five-year relative survival rates tied to ICC are poor and variable, ranging from 11% to 42%, Wessner added. Furthermore, patients often present with the disease outside the criteria for surgical resection and transplantation. Y90-TARE uses glass or resin beads containing Y...
Source: AuntMinnie.com Headlines - Category: Radiology Authors: Tags: Ultrasound Source Type: news